Innoviva (INVA) EPS (Basic) (QoQ) (2010 - 2026)
Innoviva (INVA) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,092.12% |
| Dec 31, 2025 | -116.36% |
| Sep 30, 2025 | 52.98% |
| Jun 30, 2025 | 236.36% |
| Mar 31, 2025 | -199.90% |
| Dec 31, 2024 | -600.97% |
| Sep 30, 2024 | 108.91% |
| Jun 30, 2024 | -195.97% |
| Mar 31, 2024 | 121.51% |
| Dec 31, 2023 | -247.67% |
| Sep 30, 2023 | 9,188.83% |
| Jun 30, 2023 | -96.19% |
| Mar 31, 2023 | 325.24% |
| Dec 31, 2022 | -105.64% |
| Sep 30, 2022 | 29,919.04% |
| Jun 30, 2022 | -94.06% |
| Mar 31, 2022 | 141.47% |
| Dec 31, 2021 | -114.87% |
| Sep 30, 2021 | 265.69% |
| Jun 30, 2021 | 8.33% |